Gilead Sciences (GILD) Price to Book (2009 - 2026)

Gilead Sciences (GILD) has reported Price to Book for 18 consecutive years, with 13.25 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 88.57% year-over-year to 13.25; the trailing twelve-month figure through Jun 2026 stood at 13.25 (up 88.57% YoY), and the FY2025 full-year result was 6.71, up 12.19% from the prior year.
• Price to Book grew to 13.25 in Q2 2026 per GILD's latest filing, from 7.39 in the prior quarter.
• Across five years, Price to Book topped out at 13.25 in Q2 2026 and bottomed at 3.67 in Q3 2022.
• Historically, Price to Book has averaged 5.78 across 5 years, with a median of 5.14 in 2022.
• The sharpest annual moves came in 2022 and 2026: Price to Book declined 12.48% in 2022, then jumped 88.57% in 2026.
• Over 5 years, Price to Book stood at 5.05 in 2022, then retreated by 12.1% to 4.44 in 2023, then jumped by 34.78% to 5.98 in 2024, then rose by 12.19% to 6.71 in 2025, then soared by 97.56% to 13.25 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 13.25, 7.39, and 6.71 for Q2 2026, Q1 2026, and Q4 2025 respectively.